TGFB1 and exocrine pancreatic carcinoma: The distinct activation states of TGFβ signaling in pancreatic carcinoma may thus be a reflection of the fact that TGFβ signaling itself is a double-edged sword, conferring advantages and disadvantages to the tumor.